Detalhe da pesquisa
1.
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study.
Nutr Metab Cardiovasc Dis
; 32(3): 684-691, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991937